On Tuesday, Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), loss -3.29% to $122.15.
Vertex Pharmaceuticals, stated merged financial results for the quarter ended March 31, 2015. Vertex also reiterated its financial guidance for total 2015 KALYDECO revenues and non-GAAP operating expenses.
First Quarter 2015 Non-GAAP Financial Results
- The non-GAAP financial results for the first quarter 2015 and first quarter 2014 exclude stock-based compensation expense, costs related to the relocation of the company’s corporate headquarters, hepatitis C-related revenues and costs and other adjustments.
- Total non-GAAP revenues for the first quarter of 2015 were $135.4 million, counting $130.2 million in net product revenues from KALYDECO and $5.3 million from royalty revenues.
- Vertex’s first quarter 2015 net product revenues from KALYDECO were $130.2 million contrast to $99.5 million for the first quarter of 2014. The raised KALYDECO net product revenues, contrast to the first quarter of 2014, resulted primarily from additional people being treated with KALYDECO in both U.S. and ex-U.S. markets.
- Total combined non-GAAP COR expenses for the first quarter of 2015 were $10.7 million, contrast to $9.6 million for the first quarter of 2014.
Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. The company focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF); and advancing its research and early-stage development programs.
Shares of Accuray Incorporated (NASDAQ:ARAY), declined -3.29% to $6.77, during its last trading session.
Accuray Incorporated, declared that administration is planned to present at the Bank of America Merrill Lynch 2015 Healthcare Conference in Las Vegas on Tuesday, May 12, 2015 at 2:20pm PT.
Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body.
At the end of Tuesday’s trade, Shares of CSX Corp. (YSE:CSX), dipped -3.28% to $35.41.
CSX Corporation, declared the winners of its 21st annual Chemical Safety Excellence Award, recognizing 70 customers for their commitment to the safe transportation of hazardous materials by rail.
CSX and its customers work together to ensure that hazardous materials move in the safest equipment and employees are trained on safe loading and handling procedures. The Chemical Safety Excellence Awards are presented to customers across a wide variety of industries who ship more than 600 carloads of hazardous materials during the year without a release due to controllable factors.
Many of the 2014 recipients are repeat winners, demonstrating an ongoing commitment to safety in addition to their lasting partnership. CSX recognized a continued commitment to excellence in the top group of companies who have made the list for 10 years: AkzoNobel Chemicals, Inc. International Chemical Company and Westlake Chemical. CSX also acknowledged companies who have been listed for five years: Ascend Performance Materials, Aux Sable Liquid Products, Cargill, Dow Corning, MarkWest Hydrocarbon, Inc., SABIC Americas, Inc. and United Refining Company.
CSX Corporation, together with its auxiliaries, provides rail-based transportation services in the United States and Canada. It offers traditional rail services, and transports intermodal containers and trailers.
Finally, Harman International Industries, Incorporated (NYSE:HAR), ended its last trade with -3.27% loss, and closed at $123.12.
Harman International Industries, declared that two-time NBA All-Star Stephen Curry (@StephenCurry30) has been named the newest Brand Ambassador for the company’s JBL® audio brand. Curry has entered a multi-year partnership to collaborate with JBL in marketing and advertising efforts for the development of fan-centric integrated content and programs for social media and television. HARMAN is the official headphone, speaker and audio partner of the NBA, Women’s National Basketball Association (WNBA), NBA Development League (NBA D-League), and USA Basketball, following the launch of a comprehensive multiyear marketing and licensing partnership in September 2014.
Entering the league six years ago as the seventh overall pick in the NBA Draft 2009 presented by State Farm, Curry quickly became one of the premier point guards in the league and continues to propel his game forward, recently breaking his own record for most three-point field aims made in a season, and winning the Foot Locker Three-Point Contest during NBA All-Star 2015 in New York City. His determination and extraordinary work ethic have led him to being widely considered a front-runner for the 2014-15 Kia NBA Most Valuable Player Award. Curry’s commitment to excelling in all facets of his basketball performance exemplifies JBL’s holistic approach to developing state-of-the-art audio products that push every boundary of innovation.
Curry joins Damian Lillard as the second NBA player serving as an ambassador for JBL, and a roster of global brand representatives who partner with HARMAN, counting GRAMMY® Award-winning rock bands Maroon 5 and Linkin Park; global musician, producer, artist and humanitarian Quincy Jones; Indian film composer, record producer, musician, singer and philanthropist AR Rahman; and international piano superstar and United Nations Messenger of Peace Lang Lang.
Harman International Industries, Incorporated develops, manufactures, and markets audio products, lighting solutions, and electronic systems, in addition to digitally integrated audio and infotainment systems for the automotive industry worldwide. Its Infotainment segment offers infotainment systems for vehicle applications to be installed primarily as original equipment by automotive manufacturers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
